samedan logo
 
 
spacer
home > pmps > spring 2004 > how new materials and technologies are putting validated shipping within reach of everyone
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

How New Materials and Technologies are putting Validated Shipping within Reach of Everyone

Continuing globalisation of operations in the pharmaceutical industry has greatly accelerated the need for new types of validated temperature-controlled packaging (TCP) that can offer a variety of different options. Due to a vast increase in the global traffic of infectious substances, diagnostic specimens, vaccines and blood products, there has been a growing need for TCP operating at parameters from -500C to +370C. These products are being employed over increasingly longer distances, through more variable temperate zones and through an expanding number of jurisdictions in ever-extending warm and cold chains.

Both warm and cold chains offer a system of ensuring product quality and safety up until it reaches the end user. The 'chain' refers to each stage in the storage and shipping of the product, which is joined to the other links by documentation and recording. As the chains involved in temperature-controlled shipping have increased, so have the demands made on TCP.

Ever-increasing regulation is also playing a major part in this process. It is axiomatic that the efficacy of many temperature-sensitive medicinal products may be compromised if they are permitted to remain outside of their specified temperature band, and it is for this reason that regulatory bodies keep an ever tightening grip on the procedures and processes of good manufacturing and good distribution practice. The needs of both pharmaceutical professionals and the demands of regulators are therefore jointly driving the designers and manufacturers of TCP. The difficulty of this task is illustrated by the fact that the EU alone has no less than 15 different regulatory bodies.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Katrina Bray, Marketing Manager at Laminar Medica

Katrina Bray is the Marketing Manager at Laminar Medica Limited. For the last six years she has gained extensive knowledge in the field of cold chain distribution within the pharmaceutical industry. Katrina has also recently been involved in setting up the strategic alliance for European distribution between Laminar and Saf-T-Pak Inc, an infectious substance and diagnostic packaging company.
spacer
Katrina Bray
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera to build state-of-the-art manufacturing facility in Poland to serve more customers and patients

Based in Szczecin, this facility extends Nemera’s manufacturing capabilities and will bring more drug delivery device solutions to patients. Following the dynamic growth of the drug delivery devices market, as a world leader, Nemera is thrilled to extend its manufacturing capabilities in Poland.
More info >>

White Papers

Another Successful Visit Against the Odds

Medical Research Network (MRN) Limited

Our dedicated team of nurses, couriers and project managers deliver, come rain or shine. Making sure a Clinical Trial visit can go ahead in the home can be a complex process, and last month bad weather nearly stopped play on an important Home Trial Support visit. Thanks to the commitment and dedication from the entire team it went ahead against the odds.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement